Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 1 , Pages 49-55 , January 2010

Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat

  • E. Velkoska

      Affiliations

    • Department of Pharmacology, The University of Melbourne, Parkville, Victoria 3010, Australia
    • ,
  • F.J. Warner

      Affiliations

    • Liver Cell Biology, Centenary Institute, Camperdown NSW 2050, Australia
    • ,
  • T.J. Cole

      Affiliations

    • Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia
    • ,
  • I. Smith

      Affiliations

    • Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia
    • ,
  • M.J. Morris

      Affiliations

    • Department of Pharmacology, School of Medical Sciences, University of New South Wales, Kensington NSW 2052, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 2 9385 1560; fax: +61 2 9385 1059.

Received 10 October 2008 ,Revised 10 February 2009 ,Accepted 10 February 2009.

References 

  1. Hall JE, Brands MW, Hildebrandt DA, Kuo J, Fitzgerald S. Role of sympathetic nervous system and neuropeptides in obesity hypertension. Braz J Med Biol Res. 2000;33:605–618
  2. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol. 2004;287:R943–R949
  3. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest. 1986;78:31–39
  4. Cassis L, Saye J, Peach M. Location and regulation of rat angiotensinogen messenger RNA. Hypertension. 1988;11:591–596
  5. Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension. 2000;35:1270–1277
  6. Jonsson JR, Game PA, Head RJ, Frewin DB. The expression and localisation of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood Press. 1994;3:72–75
  7. Pinterova L, Krizanova O, Zorad S. Rat epididymal fat tissue express all components of the renin-angiotensin system. Gen Physiol Biophys. 2000;19:329–334
  8. Crandall D, Herzlinger H, Saunders B, Armellino D, Kral J. Distribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res. 1994;35:1378–1385
  9. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension. 2005;45:356–362
  10. Goossens GH, Blaak EE, van Baak MA. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev. 2003;4:43–55
  11. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, et al. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci USA. 2008;105:6531–6536
  12. Hypertension Study Group Investigators . Enalapril in essential hypertension: a comparative study with propranolol. Enalapril in Hypertension Study Group (UK). Br J Clin Pharmacol. 1984;18:51–56
  13. McGrath BP, Matthews PG, Louis W, Howes L, Whitworth JA, Kincaid-Smith PS, et al. Double-blind study of dilevalol and captopril, both in combination with hydrochlorothiazide, in patients with moderate to severe hypertension. J Cardiovasc Pharmacol. 1990;16:831–838
  14. Duncan AM, Burrell LM, Kladis A, Campbell DJ. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. J Cardiovasc Pharmacol. 1996;28:746–754
  15. Setoguchi Y, Ohnuki T, Rashid M, Nakamura T, Hattori K, Nagatomo T, et al. Effects of chronic administration of sarpogrelate on systolic blood pressure of spontaneously hypertensive rats: comparison with quinapril. Pharmacology. 2002;64:71–75
  16. Scheen AJ, Luyckx FH. Obesity and liver disease. Best Pract Res Clin Endocrinol Metab. 2002;16:703–716
  17. den Boer M, Voshol PJ, Kuipers F, Havekes LM, Romijn JA. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. Arterioscler Thromb Vasc Biol. 2004;24:644–649
  18. Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J. 2005;19:136–138
  19. Hansen MJ, Jovanovska V, Morris MJ. Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high-fat feeding in the rat. J Neurochem. 2004;88:909–916
  20. Widdop RE, Sampey DB, Jarrott B. Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats. Hypertension. 1999;34:964–968
  21. Duke LM, Paull JR, Widdop RE. Cardiovascular status following combined angiotensin-converting enzyme and AT1 receptor inhibition in conscious spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2003;30:317–323
  22. Burrell LM, Risvanis J, Kubota E, Dean RG, MacDonald PS, Lu S, et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J. 2005;26:369–375
  23. Barton M, Carmona R, Morawietz H, d'Uscio LV, Goettsch W, Hillen H, et al. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension. 2000;35:329–336
  24. Masuo K, Mikami H, Ogihara T, Tuck ML. Weight reduction and pharmacologic treatment in obese hypertensives. Am J Hypertens. 2001;14:530–538
  25. Scholze J, Grimm E, Herrmann D, Unger T, Kintscher U. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. Circulation. 2007;115:1991–1998
  26. Campbell DJ, Duncan AM, Kladis A, Harrap SB. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1995;26:426–436
  27. Aguilera G, Young WS, Kiss A, Bathia A. Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II. Neuroendocrinology. 1995;61:437–444
  28. Porter JP, Potratz KR. Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am J Physiol Regul Integr Comp Physiol. 2004;287:R422–R428
  29. Cassis LA, English VL, Bharadwaj K, Boustany CM. Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology. 2004;145:169–174
  30. Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr. 2004;79:502–509
  31. Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology. 2002;35:762–771
  32. Van Steenbergen W, Lanckmans S. Liver disturbances in obesity and diabetes mellitus. Int J Obes Relat Metab Disord. 1995;19(Suppl. 3):S27–S36
  33. Ran J, Hirano T, Adachi M. Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats. Am J Physiol Endocrinol Metab. 2004;287:E227–E232
  34. Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F. Enalapril prevents fatty liver in nephrotic rats. J Nephrol. 2002;15:358–367
  35. Sharma AM. Is there a rationale for angiotensin blockade in the management of obesity hypertension?. Hypertension. 2004;44:12–19
  36. Henriksen EJ, Jacob S. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism. 1995;44:267–272
  37. Carvalho CR, Thirone AC, Gontijo JA, Velloso LA, Saad MJ. Effect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes. 1997;46:1950–1957
  38. Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, et al. Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006;355:1551–1562

☆ This work was presented in abstract form to the International Congress of Obesity, Sydney, September 2006.

PII: S0939-4753(09)00036-2

doi: 10.1016/j.numecd.2009.02.004

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 1 , Pages 49-55 , January 2010

Article Tools

* Image Usage & Resolution